The Interventional Cardiology Devices Market report segments the industry into By Product Type (Coronary Stents, Catheters, Percutaneous Transluminal Coronary Angioplasty (PTCA) Balloons, Percutaneous Transluminal Coronary Angioplasty (PTCA) Guide Wires, Other Product Types) and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America).

The global interventional cardiology devices market size reached USD 24.5 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 43.2 Billion by 2033, exhibiting a growth rate (CAGR) of 6.53% during 2025-2033. The rising prevalence of cardiovascular diseases, aging population, ongoing technological advancements, and increasing shift towards minimally invasive procedures are primarily driving the market's growth.

IMARC Group provides an analysis of the key trends in each segment of the global interventional cardiology devices market report, along with forecasts at the global, regional, and country levels from ​​​​​​​2025-2033. Our report has categorized the market based on product and end user.

The India Cardiovascular Devices Market report segments the industry into By Device Type (Diagnostic and Monitoring Devices [Electrocardiogram (ECG), Remote Cardiac Monitoring, and more], Therapeutic and Surgical Devices [Cardiac Assist Devices, Cardiac Rhythm Management Devices, Catheter, and more]).

The Cardiovascular Device Market Share size and share are expected to exceed USD 128.23 billion by 2034, with a compound annual growth rate (CAGR) of 8.4%.

[309 Pages Report] Global demand for interventional cardiology devices is anticipated to record a CAGR of 8.4% during the forecast period (2022 to 2032). The interventional cardiology devices market is expected to be valued at US$ 16.4 Billion in 2022 and is likely to reach US$ 36.9 Billion by 2032.

What is the Regional Analysis for the Interventional Cardiology Devices Market?

The global cardiovascular devices market size reached USD 62.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 101.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.5% during 2025-2033. The introduction of interventional cardiology procedures, coupled with favorable reimbursement policies, are stimulating the market growth

IMARC Group provides an analysis of the key trends in each segment of the market, along with the cardiovascular devices market forecast at the global, regional, and country levels for 2025-2033. Our report has categorized the market based on the device type, application, and end user.

Interventional Cardiology Devices Market is growing at a CAGR of 7.40% over the next 7 years. Abbott Laboratories, Terumo Medical Corporation, Boston Scientific Corporation, Cardinal Health, Medtronic, Cook and many more major companies operating in this Market.

This statistic depicts the global interventional cardiology devices market in 2013 and a forecast for 2022. The global market value for cardiology devices is projected to reach 11.2 billion U.S. dollars by 2022.

Snapshot img

Cardiovascular Medical Devices Market Size 2024-2028

The cardiovascular medical devices market size is forecast to increase by USD 19.08 billion at a CAGR of 7.2% between 2023 and 2028.

The market is witnessing significant growth due to the increasing prevalence of cardiac conditions such as atrial fibrillation and clogged arteries. This trend is driven by the rising number of individuals with these conditions and the growth of insurance providers covering diagnostic monitoring devices. companies in this market are focusing on innovative technologies like Al and machine learning based electrocardiogram (ECG) technology to improve the accuracy and efficiency of cardiovascular diagnosis. Surgical devices, including ECG, Holter monitors, event monitors, and implantable loop recorders, are essential tools for the early detection and treatment of cardiovascular diseases. However, the high cost of cardiovascular procedures remains a challenge for market growth. To stay competitive, companies must offer cost-effective solutions while maintaining the highest standards of quality and patient safety. This market analysis report provides a comprehensive overview of the market growth factors, business strategies, and challenges shaping the future of the cardiovascular medical devices industry.

What will be the Size of the Market During the Forecast Period?

Request Free Sample

The market holds significant importance in the healthcare industry as these devices play a crucial role in diagnosing, monitoring, and treating various heart disorders. Heart diseases, including heart failure, cardiomyopathy, and stroke, are fatal conditions that pose a major health concern worldwide. According to the World Health Organization (WHO), cardiovascular diseases accounted for approximately 17.9 million deaths in 2016. Minimally invasive procedures and advanced cardiovascular devices have revolutionized the treatment landscape, offering improved patient outcomes and reduced healthcare resources. Diagnostic monitoring devices, such as ECG and Holter monitors, enable early detection and timely intervention, thereby reducing the risk of complications and mortality.
In addition, cardiology devices, including coronary artery stents and surgical devices, have significantly contributed to the advancement of cardiovascular care. For instance, coronary artery stents help in the treatment of coronary artery diseases by improving blood flow and reducing the risk of heart attacks. Artificial intelligence (AI) is increasingly being integrated into cardiovascular devices to enhance their functionality and accuracy. AL-based ECG technology, for example, can analyze ECG data more efficiently and accurately than traditional methods, enabling early detection and diagnosis of heart conditions. The cardiovascular devices market is expected to witness steady growth due to the increasing prevalence of heart disorders and the need for advanced diagnostic and therapeutic solutions.

How is this market segmented and which is the largest segment?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Product

  Diagnostic and monitoring systems
  Surgical devices


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK
    France
    Italy


  Asia

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

By Product Insights

The diagnostic and monitoring systems segment is estimated to witness significant growth during the forecast period.

The diagnostic and monitoring segment of the international market comprises various devices that play a vital role in evaluating heart health, identifying cardiovascular diseases (CVDs) in their initial stages, and tracking disease progression or treatment response. This segment includes devices like ECGs, which measure the electrical activity of the heart and are crucial for diagnosing arrhythmias, heart attacks, and other cardiac conditions. Furthermore, echocardiograms, which employ ultrasound technology to generate detailed images of the heart, aid in assessing structural heart diseases and evaluating heart function. Portable ECG devices, such as Holter monitors and event monitors, are also part of this segment. These devices enable continuous heart monitoring over extended durations, allowing doctors to detect irregularities that may not surface during routine ECG tests.

Get a glance at the market report of share of various segments Request Free Sample

The diagnostic and monitoring systems segment was valued at USD 21.14 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 38% to the growth of the global market during the fore

This statistic shows the market share for global interventional cardiology devices in 2017 and a forecast for 2027, by end user. It is forecasted that the market share of hospitals as the end user of such devices will decrease slightly from 56.4 percent to 54.6 percent within this period.

The global interventional cardiology devices market size was USD 13.72 Billion in 2020 and is expected to reach USD 26.84 Billion in 2028 and register a CAGR of 8.7%. Interventional cardiology devices industry report classifies global market by share, trend, and on the basis of product type, end-use...

Cardiology Surgical & Interventional Cardiology Devices Market Outlook

The global cardiology surgical & interventional cardiology devices market size was valued at approximately USD 23 billion in 2023 and is forecasted to reach around USD 38 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.0% during the forecast period. This promising growth is primarily fueled by the rising prevalence of cardiovascular diseases worldwide, advancements in medical technology, and the growing demand for minimally invasive surgical procedures. The increased global health awareness and the consequent rise in health check-ups have amplified the demand for diagnostic and therapeutic cardiology devices, further contributing to the market's expansion.

One of the pivotal growth factors is the aging global population, which is more susceptible to cardiovascular ailments. As life expectancy rises worldwide, the prevalence of heart diseases is expected to surge, creating a robust demand for surgical and interventional cardiology devices. Additionally, lifestyle changes such as increasing obesity rates, sedentary lifestyles, and unhealthy diets have contributed to a higher incidence of heart-related issues. These factors are expected to escalate the demand for both surgical and interventional solutions, driving the market growth over the forecast period.

Technological advancements in cardiology devices are another significant driver for market growth. Innovations, including drug-eluting stents, bioresorbable vascular scaffolds, and advanced catheters, have significantly enhanced the effectiveness and safety of cardiac procedures. These advancements reduce the recovery time and improve patient outcomes, further propelling the adoption of cardiology devices. Moreover, the integration of artificial intelligence and data analytics in these devices provides real-time monitoring and diagnostics, which is crucial for both preventive and interventional cardiology, thereby expanding the market prospects.

Healthcare infrastructure improvements, particularly in emerging economies, are contributing to the market's growth. With increased government expenditure on healthcare and favorable reimbursement policies, there is a noticeable enhancement in the accessibility and affordability of cardiology treatments. Moreover, initiatives to establish specialized cardiac centers and the growing inclination towards ambulatory surgical centers for minor procedures are fostering market expansion. Alongside, educational initiatives that increase awareness about early diagnosis and treatment options are also playing a critical role in expanding the market's reach.

Regionally, North America dominates the market owing to its advanced healthcare infrastructure, high healthcare expenditure, and the presence of leading market players. However, the Asia Pacific region is expected to exhibit the highest growth rate during the forecast period, fueled by increasing healthcare investments, a rapidly expanding population base, and rising incidences of lifestyle-related diseases. Europe remains a significant market due to technological advancements and the high prevalence of cardiovascular diseases. Meanwhile, the Middle East & Africa and Latin America are also showing promising growth trends due to improving healthcare facilities and rising awareness about heart health.

Product Type Analysis

The cardiology surgical & interventional cardiology devices market is segmented by product types, including stents, catheters, guidewires, balloons, and others. Stents, particularly drug-eluting stents, hold a significant market share due to their efficiency in reducing the risk of restenosis, a common post-procedural complication. The technological advancements in stent design, such as biodegradable and bioresorbable stents, continue to drive their demand in the market. Moreover, the growing research and development activities aimed at improving the functionality and safety profile of stents are further propelling their market growth.

Catheters are another vital segment in the market, as they are crucial in various diagnostic and therapeutic procedures, including angioplasty and electrophysiology. The ongoing advancements in catheter technology, such as improvement in material composition and design, have significantly enhanced their application in minimally invasive procedures, driving their market demand. The introduction of smart catheters equipped with sensors for real-time feedback and navigation has opened new growth avenues for this segment, aiding the market's expansion.</p&g

This statistic shows the global interventional cardiology devices market in 2017 and a forecast for 2027, in billion U.S. dollars. It is forecasted that the market will generate revenues of some 25 billion U.S. dollars by 2027.

Interventional Cardiology Devices Market size was valued at USD 18.43 Billion in 2024 and is projected to reach USD 33.49 Billion by 2031, growing at a CAGR of 8.55% from 2024 to 2031.

Interventional Cardiology Devices Market: Definition/ Overview

Interventional cardiology devices encompass a wide range of medical instruments, tools, and implants designed for use in minimally invasive procedures to diagnose and treat cardiovascular diseases. These devices are typically deployed through catheters inserted into blood vessels, enabling cardiologists to access the heart and surrounding vasculature without the need for open surgery. Interventional cardiology procedures are performed in specialized catheterization labs, often referred to as "cath labs." PCI procedures, also known as coronary angioplasty with stenting, involve the use of interventional cardiology devices to treat coronary artery disease by removing plaque buildup and improving blood flow to the heart. PCI procedures are used to treat conditions such as angina, myocardial infarction (heart attack), and acute coronary syndromes. Interventional cardiology devices are employed in the treatment of peripheral artery disease (PAD) and other vascular conditions affecting the arteries and veins outside the heart. These procedures may include balloon angioplasty, atherectomy, thrombectomy, and the placement of stents or drug-coated balloons to restore blood flow in the peripheral vasculature.

The size and share of this market is categorized based on Cardiac Rhythm Management Devices (Pacemakers, Implantable Cardioverter Defibrillators (ICDs), Cardiac Resynchronization Therapy Devices, Remote Monitoring Devices, Wearable Cardiac Monitors) and Interventional Cardiology Devices (Coronary Stents, Balloon Angioplasty Catheters, Guidewires, Balloon Inflation Devices, Thrombectomy Devices) and Cardiovascular Surgical Devices (Heart Valve Devices, Aortic Grafts, Coronary Artery Bypass Grafting (CABG) Devices, Endovascular Stent Grafts, Surgical Instruments) and Vascular Devices (Peripheral Stents, Balloons, Embolic Protection Devices, Endovenous Laser Treatment Devices, Intravascular Ultrasound Devices) and Monitoring Devices (Electrocardiograms (ECGs), Holter Monitors, Event Monitors, Blood Pressure Monitors, Implantable Loop Recorders) and geographical regions (North America, Europe, Asia-Pacific, South America, Middle-East and Africa).

Japan interventional cardiology devices market size reached USD 1.1 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.4 Billion by 2033, exhibiting a growth rate (CAGR) of 8.3% during 2025-2033. The rising prevalence of cardiac ailments, recent advancements in medical technology, introduction of supportive policies, and the growing preference for minimally invasive (MI) procedures over traditional surgeries represent some of the key factors driving the market.

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2025-2033. Our report has categorized the market based on product and end user.

The China Cardiovascular Devices Market report segments the industry into By Device Type (By Diagnostic and Monitoring Devices, By Therapeutic and Surgical Devices), By Diagnostic and Monitoring Devices (Electrocardiogram (ECG), Remote Cardiac Monitoring, and more), and By Therapeutic and Surgical Devices (Cardiac Assist Devices, Cardiac Rhythm Management Devices, Catheter, and more).

The global cardiovascular devices market size was valued at over USD 62.95 billion in 2024 and is expected to expand at a CAGR of around 6.9%, surpassing USD 149.87 billion revenue by 2037. Coronary Artery Diseases segment is expected to lead the market with the largest share, driven by the high global mortality rate due to CAD.

Global Cardiovascular Devices market size is expected to reach $102 billion by 2029 at 6.3%, rising prevalence of cardiovascular disorders fuels growth in the cardiovascular device market

The United Kingdom Cardiovascular Devices Market is Segmented by Device Type (Diagnostic And Monitoring Market and Therapeutic And Surgical Devices). The Report Offers the Value (In USD Million) For the Above Segments.